Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Rheumatology (Oxford, England)|July 29, 2022
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC modelAlexandru Garaiman, Klaus Steigmiller, Catherine Gebhard, et al.Annals of the Rheumatic Diseases|February 10, 2015
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO studyJudith Haschka, Matthias Englbrecht, Axel J Hueber, et al.Haematologica|January 18, 2020
Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working PartyJoerg Henes, Maria Carolina Oliveira, Myriam Labopin, et al.RMD Open|April 17, 2023
Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseasesRebecca Hasseli, Jutta G Richter, Bimba Franziska Hoyer, et al.Annals of the Rheumatic Diseases|October 21, 2015
Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatmentJuergen Rech, Axel J Hueber, Stephanie Finzel, et al.Annals of the Rheumatic Diseases|June 22, 2016
Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugsCamille P Figueiredo, Holger Bang, Jayme Fogagnolo Cobra, et al.Annals of the Rheumatic Diseases|February 2, 2025
Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR databaseQingran Yan, Cosimo Bruni, Alexandru Garaiman, et al.The Lancet. Rheumatology|February 1, 2024
Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trialKoray Tascilar, Melanie Hagen, Arnd Kleyer, et al.Journal of Clinical Medicine|June 10, 2023
Physical Function of RA patients Tapering Treatment-A Post Hoc Analysis of the Randomized Controlled RETRO TrialMarlene Stephan, Koray Tascilar, Melek Yalcin-Mutlu, et al.BMJ Open|March 19, 2021
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocolJulia Spierings, Anna van Rhenen, Paco Mw Welsing, et al.Pageof 5